- Report
- June 2024
- 132 Pages
North America
From €3638EUR$4,000USD£3,117GBP
- Report
- May 2024
- 182 Pages
Global
From €4092EUR$4,500USD£3,506GBP
- Report
- February 2024
- 184 Pages
Global
From €4092EUR$4,500USD£3,506GBP
- Report
- February 2024
- 185 Pages
Global
From €4092EUR$4,500USD£3,506GBP
- Report
- February 2024
- 182 Pages
Global
From €4092EUR$4,500USD£3,506GBP
- Report
- November 2023
- 180 Pages
Global
From €4092EUR$4,500USD£3,506GBP
- Report
- October 2023
- 140 Pages
North America
From €3638EUR$4,000USD£3,117GBP
- Report
- July 2023
- 74 Pages
Australia
From €3183EUR$3,500USD£2,727GBP
- Report
- July 2023
- 75 Pages
United States
From €3183EUR$3,500USD£2,727GBP
- Report
- June 2026
- 110 Pages
Global
From €4320EUR$4,750USD£3,701GBP
- Report
- July 2024
- 110 Pages
Global
From €4320EUR$4,750USD£3,701GBP
- Report
- April 2024
- 29 Pages
Global
From €1773EUR$1,950USD£1,519GBP
- Report
- January 2024
- 27 Pages
Global
From €1773EUR$1,950USD£1,519GBP
- Report
- June 2023
- 33 Pages
Global
From €1773EUR$1,950USD£1,519GBP
- Report
- June 2023
- 34 Pages
Global
From €1773EUR$1,950USD£1,519GBP
- Report
- January 2023
- 38 Pages
Global
From €2660EUR$2,925USD£2,279GBP
- Report
- August 2024
Global
From €2228EUR$2,450USD£1,909GBP
- Report
- February 2024
- 75 Pages
Global
From €4502EUR$4,950USD£3,857GBP
- Report
- October 2022
- 71 Pages
Global
- Report
- November 2021
- 106 Pages
Global
From €4502EUR$4,950USD£3,857GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more